- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.03. | Agiliti EVP & GC sells shares worth over $47,000 | 1 | Investing.com | ||
| 23.03. | Agiliti EVP & GC sells $47k in company stock | 1 | Investing.com | ||
| 18.03. | AGILITI, INC. \DE - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 05.03. | Agiliti reports earnings beat, revenue growth in fourth quarter | 1 | Investing.com | ||
| 05.03. | AGILITI, INC. \DE - 8-K, Current Report | 1 | SEC Filings | ||
| 05.03. | Agiliti Announces Financial Results for Fourth Quarter and Full-Year 2023 | 56 | Business Wire | EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Agiliti Inc. (NYSE: AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced... ► Artikel lesen | |
| 04.03. | Earnings Outlook For Agiliti | 1 | Benzinga.com | ||
| 27.02. | Agiliti Being Taken Private By THL Partners In $2.5 Billion Deal | 1 | pulse2.com | ||
| 27.02. | Agiliti to go private in $2.5B buyout deal by majority shareholder | 1 | FierceBiotech | ||
| 27.02. | Jefferies downgrades Agiliti stock as THL Partners buys remaining shares | 2 | Investing.com | ||
| 27.02. | US Agiliti, Domino's Pizza, Krystal Biotech | 7 | Reuters | ||
| 26.02. | Why Agiliti Stock Is Up Today | 1 | Benzinga.com | ||
| 26.02. | Healthcare tech Agiliti to be taken private in $2.5 billion deal | 1 | Reuters | ||
| 26.02. | Agiliti surges on $1.35 billion go-private deal | 1 | Reuters | ||
| 26.02. | Agiliti to go private in $2.5B deal with Thomas H. Lee Partners | 1 | Seeking Alpha | ||
| 26.02. | Agiliti to be taken private by THL Partners in a $1.35bn deal; shares pop 30% | 1 | Investing.com | ||
| 26.02. | Agiliti Enters Merger Agreement | - | RTTNews | ||
| 26.02. | Healthcare tech Agiliti to be taken private for $1.35 billion | 2 | Reuters | ||
| 26.02. | Healthcare tech Agiliti to be taken private by THL Partners in $2.5 billion deal | 2 | Reuters | ||
| 26.02. | Agiliti agrees to $2.5 billion buyout by Thomas H. Lee Partners | 1 | Investing.com |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 11,854 | -4,82 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| NANO-X IMAGING | 9,100 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 0,707 | 0,00 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
| GOODRX | 6,960 | 0,00 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 12,280 | 0,00 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
| CARMAT | 3,215 | -12,16 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
| PROGYNY | 32,600 | 0,00 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
| HYPERFINE | 0,810 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| MIMEDX | 6,430 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results | Net Sales Grew 17% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter Net Income was $53 million, Inclusive of a $40 million One-Time Non-Cash Tax Benefit Fourth Quarter... ► Artikel lesen | |
| BIOMERICA | 0,713 | 0,00 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
| ATRICURE | 23,050 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
| ATRION | 394,00 | +4,79 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| OUTSET MEDICAL | 2,550 | 0,00 % | Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis | ||
| AMWELL | 0,531 | 0,00 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
| TALKSPACE | 3,070 | 0,00 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen |
Das Unternehmen AGILITI INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 10,105 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
